Related references
Note: Only part of the references are listed.Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management
Yan Li et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Convalescent plasma as a potential therapy for COVID-19
Long Chen et al.
LANCET INFECTIOUS DISEASES (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?
Mayda Gursel et al.
ALLERGY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2
Alba Grifoni et al.
CELL HOST & MICROBE (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics
Olivia A. Vogel et al.
FRONTIERS IN MICROBIOLOGY (2020)
Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19
Maroun Khoury et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
Wei Zhang et al.
EMERGING MICROBES & INFECTIONS (2020)
Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019
Yujiao Jin et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
Samir Jawhara
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Convalescent Plasma to Treat COVID-19 Possibilities and Challenges
John D. Roback et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
SARS-CoV-2: a storm is raging
Savannah F. Pedersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019
Qing-Lei Zeng et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
Mingxiang Ye et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
The establishment of reference sequence for SARS-CoV-2 and variation analysis
Changtai Wang et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Shibo Jiang et al.
TRENDS IN IMMUNOLOGY (2020)
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
Jiahua He et al.
VIRUSES-BASEL (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Janice Hopkins Tanne
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base
Fabio S. Taccone et al.
LANCET RESPIRATORY MEDICINE (2020)
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing as the of SARS-CoV-2
Ye Qiu et al.
MICROBES AND INFECTION (2020)
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
Wei Cao et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends
Sandeep Kumar Vashist
DIAGNOSTICS (2020)
Therapeutic plasma exchange in adults with severe COVID-19 infection
Faryal Khamis et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study
Hassan Abolghasemi et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia
Mehmet Ali Erkurt et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Janice S. Mani et al.
VIRUS RESEARCH (2020)
Severe refractory COVID-19 patients responding to convalescent plasma; A case series
Hadi Mohammed Abdullah et al.
ANNALS OF MEDICINE AND SURGERY (2020)
Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau
Iek Long Lo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Bo Ram Beck et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Four human diseases with significant public health impact caused by mosquito-borne flaviviruses: West Nile, Zika, dengue and yellow fever
Jeannette Guarner et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2019)
Therapeutic strategies to target the Ebola virus life cycle
Thomas Hoenen et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Chikungunya Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention
Francesco Vairo et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Treatments for Primary Immune Thrombocytopenia: A Review
Margot Samson et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2019)
Sexual Dimorphism in Innate Immunity
Sebastien Jaillon et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)
IVIG-mediated effector functions in autoimmune and inflammatory diseases
Caroline Galeotti et al.
INTERNATIONAL IMMUNOLOGY (2017)
Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone
F. Sahr et al.
JOURNAL OF INFECTION (2017)
Pathogen Inactivation of Cellular Blood Products-An Additional Safety Layer in Transfusion Medicine
Axel Seltsam
FRONTIERS IN MEDICINE (2017)
Tackling Difficult Staphylococcus aureus Infections: Antibodies Show the Way
Bo Shopsin et al.
CELL HOST & MICROBE (2016)
Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis
Alaa Badawi et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
IVIG-mediated protection against necrotizing pneumonia caused by MRSA
Binh An Diep et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2015)
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
Yaseen Arabi et al.
SPRINGERPLUS (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
Virus reduction in an intravenous immunoglobulin by solvent/detergent treatment, ion-exchange chromatography and terminal low pH incubation
Peter L. Roberts et al.
BIOLOGICALS (2012)
Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy
S. V. Kaveri et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
Lamberto Manzoli et al.
PLOS ONE (2011)
Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients
Lifeng Liu et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
Viral safety characteristics of Flebogamma® DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin
Santiago Caballero et al.
BIOLOGICALS (2010)
A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity
G. Poelsler et al.
VOX SANGUINIS (2008)
Transfusion-related acute lung injury in the critically III: Prospective nested case-control study
Ognjen Gajic et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Viral safety of Nanogam (R), a new 15 nm-filtered liquid immunoglobulin product
FG Terpstra et al.
VOX SANGUINIS (2006)
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
KM Yeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Clinical uses of intravenous immunoglobulin
S Jolles et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
RA Tripp et al.
JOURNAL OF VIROLOGICAL METHODS (2005)
Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase
D Xu et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
J Bayry et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice
D Ben-Nathan et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
CM Booth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines
JE Crowe et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
